← Unusual insider activity · Company hub
BMY Bristol-Myers Squibb Co.
Insider figures are trailing 90 days, open-market Form 4 only. Institutional figures are the latest reported quarter. These windows are not simultaneous.
-$437K net selling - trailing 90 days
0 buyers - 2 unique sellers
Historical context: most recent complete month (2026-08) is the 48th percentile of this ticker's monthly net P/S flow over 23 complete months (limited history). Lower percentiles are more selling; higher are more buying.
6 accumulating - 7 trimming - 1 unchanged
14 comparable institutions - Q2 2026
open-market Form 4 only - grants, exercises, tax withholding excluded. ~ derived from SEC-reported shares x price.
Who is responsible
| Insider | Role | Net activity | Rows |
|---|---|---|---|
| Massacesi Cristian | EVP,Chief Med Offr,Head of Dev | -~$0.4M | 1 |
| Holzer Phil M | SVP and Controller | -~$34K | 1 |
Transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 9/9/2026 | Massacesi Cristian | EVP,Chief Med Offr,Head of Dev | S | -6249 | 64.57 | ~$0.4M |
| 8/25/2026 | Holzer Phil M | SVP and Controller | S | -500 | 67.5 | ~$34K |
| 4/1/2026 | Elkins David V | EVP, Chief Financial Officer | 2 reported sale rows | 30000 | — | ~$1.9M |
| 4/1/2026 | Elkins David V | EVP, Chief Financial Officer | S | -25519 | 61.6 | ~$1.6M |
| 4/1/2026 | Elkins David V | EVP, Chief Financial Officer | S | -4481 | 62.05 | ~$0.3M |
| 9/2/2025 | Elkins David V | EVP, Chief Financial Officer | S | -56000 | 47.33 | ~$2.7M |
| 8/2/2025 | Short Bartie Wendy | EVP, Corporate Affairs | S | -378 | 44.23 | ~$17K |
| 5/9/2025 | Hickey Benjamin | President, RayzeBio Org. | S | -97.391 | 38.01 | ~$4K |
| 4/25/2025 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | P | 4250 | 47.58 | ~$0.2M |
| 2/20/2025 | BOERNER CHRISTOPHER S. | Chief Executive Officer | P | 2000 | 55.048 | ~$0.1M |
| 2/14/2025 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | P | 1823.486 | 54.84 | ~$100K |
| 11/4/2024 | Holzer Phil M | SVP and Controller | S | -700 | 55.615 | ~$39K |
| 11/1/2024 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | P | 1830 | 54.675 | ~$0.1M |